Defense- “The devices are civilian, non-military medical products not subject to a Commerce Control List license and federal regulations specifically exempt exports to the Government of Iraq from licensing requirements. In addition, export of the devices is permitted under the FDA’s export provisions for medical devices.”Delivery System Optimized for Safety and Control
Export controls- “The medical devices sold by Cardia to the Government of Iraq are lawfully exported from the United States under the Export Administration Regulations. The devices are civilian, non-military medical products not subject to a Commerce Control List license and federal regulations specifically exempt exports to the Government of Iraq from licensing requirements.”Delivery System Optimized for Safety and Control
AI regulation- “Regulatory requirements applicable to AI and clinical decision-support technologies continue to evolve and may increase development costs, delay commercialization efforts or limit the permitted use of such technologies.”Delivery System Optimized for Safety and Control
Revenue, in its own words- “We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our common stock held by non-affiliates exceeds $700 million as of the end of the second fiscal quarter in any fiscal year before that time or if we have total annual gross revenues of $1.235 billion or more during any fiscal year before that time, in which case we would no longer be an emerging growth company as of the fiscal year end, or if we issue more than $1.0 billion in non-convertible debt during any three-year period before that time we would cease to be an emerging growth company immediately.”Delivery System Optimized for Safety and Control
Quoted from the company's own filing. Read the S-1/A at the SEC